Pretreatment regimen for high-risk patients receiving urographic contrast media.
Retrospective analysis of 85 high-risk patients, pretreated with prednisone who received urographic contrast media, was associated with no adverse effects in 76 (89.6%) procedures. Serious reactions were recorded only in 1 patient (1.1%). Based on the results, our regimen is an appropriate prophylaxis.
Moskovitz
B
B
Department of Urology, Rambam Medical Center, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa.
Levin
D R
DR
D000328:Adult; D000368:Aged; D000707:Anaphylaxis / Q000517:prevention & control*; D003973:Diatrizoate / Q000009:adverse effects*; D003974:Diatrizoate Meglumine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D011292:Premedication; D012189:Retrospective Studies; D012307:Risk Factors; D014567:Urography
D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D011241:Prednisone